FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1807-1808 October 21, 2004 Number 17

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Tracy T. Batchelor. 207 pp., illustrated. Boston, Butterworth–Heinemann, 2004. $74.95. ISBN 0-7506-7406-7.

During the past two decades, the rate of diagnosis of primary central nervous system lymphoma has more than doubled. Yet even though nearly 3 percent of brain tumors are primary central nervous system lymphomas, the various nonsurgical treatments for this disease remain unfamiliar territory to many neurologists, medical oncologists, and even experts on lymphoma. The management of the disease has drastically changed, and a growing number of patients now have a chance of a cure. Still, it is a tough disease to treat successfully. Complications of the treatment can be devastating, both in the short term and in the long . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.